In Every Issue
Editor's Note
Note to my younger self.
The Conversation
Changing with age. Getting the HIV Drug Guide in print.
Briefly
Biktarvy and antacids. Descovy FDA hearing. Updated guidelines for transgender individuals. Biktarvy and kids. PrEP4Love. Michael Johnson freed.
This Issue
Building blocks for a healthy life
Building blocks for a healthy life, with insights from a nurse educator
Partners to the End
Public-private partnerships for a vaccine sustain a global response to help end HIV
Understanding HIV-related terminology
Understanding HIV-related terminology with a glossary
Living with HIV there's just one direction - forward!
Living with HIV there's just one direction - forward!
IAS 2019 Conference Update
HIV meds just four days a week?
And other conference highlights including new long-acting drug GS-6207; PrEP on demand; HIV treatment = prevention.
Dolutegravir during pregnancy
Based on new data, the World Health Organization (WHO) recommended dolutegravir as a preferred HIV drug for all populations living with HIV, including pregnant women and those wanting to conceive.
Exciting news from Mexico City
Fostemsavir; long-acting injectable; vaginal ring
What's new in the search for a HBV and HIV cure
Current and new strategies to achieve HBV and HIV cure, and synergies between the two fields.
Features
Finding hope in ‘Crystal City’
A new documentary about gay men, meth, and HIV
What advice would you give to someone living with HIV?
What advice would you give to someone who just learned they’re living with HIV?
Truvada Safety
Talking about PrEP and HIV treatment in a time of class action lawsuits
Positively Aging: Bringing Work Back to Life
Positively Aging: Bringing Work Back to Life
Advocating for employment health
Employ This Advice
The Reunion Project Feedback Report
